Vinda International : INSIDE INFORMATION UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2019 AND NINE MONTHS ENDED 30 SEPTEMBER 2019 OF VINDA INTERNATIONAL HOLDINGS LIMITED AND UNAUDITED THIRD QUARTER RESULTS FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2019 AND NINE MONTHS ENDED 30 SEPTEMBER 2019 OF THE CONTROLLING SHAREHOLDER

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Vinda International Holdings Limited

維達國際控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 3331)

INSIDE INFORMATION

UNAUDITED FINANCIAL INFORMATION FOR THE THREE

MONTHS ENDED 30 SEPTEMBER 2019 AND

NINE MONTHS ENDED 30 SEPTEMBER 2019 OF VINDA INTERNATIONAL HOLDINGS LIMITED AND

UNAUDITED THIRD QUARTER RESULTS

FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2019

AND

NINE MONTHS ENDED 30 SEPTEMBER 2019 OF

THE CONTROLLING SHAREHOLDER

The board of directors (the "Board") of Vinda International Holdings Limited (the "Company", together with its subsidiaries, the "Group") is pleased to announce the unaudited financial information of the Group's business for the three months ended 30 September 2019 ("2019Q3") and nine months ended 30 September 2019 ("9M2019").

This announcement is made pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and the Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

1

UNAUDITED FINANCIAL INFORMATION FOR 2019Q3 AND 9M2019 OF THE GROUP

The Group continued the strong growth momentum in the first nine months of 2019. Thanks to our effective business strategy, the soft pulp prices and a better product mix, the Group successfully achieved a double-digit growth in revenue and improved margins. The Group will continue to enhance our portfolio mix, keep stringent control on costs and launch new products.

Looking forward, the Group is confident to deliver a set of solid 2019 annual results amidst the intensifying market competition, the US-China trade tensions and the continuous depreciation of Renminbi.

Compared to the three months ended 30 September of 2018 ("2018Q3"), the unaudited financial information of the Group for 2019Q3:

• For 2019Q3, total revenue increased by 12.5% (14.6% at constant exchange rate) to HK$3,838 million, of which HK$3,131 million was from the Tissue segment and HK$707 million was from the Personal Care segment.
• Gross profit for 2019Q3 increased notably by 30.1% to HK$1,202 million. Gross margin increased by 4.2 percentage points ("ppt(s)") to 31.3%.
• Total foreign exchange loss was HK$38 million (2018Q3: HK$43 million loss), of which
  HK$37 million loss was from operating payable items (2018Q3: HK$46 million loss),
  and HK$1 million loss was from financing items (2018Q3: HK$3 million gain).
• Operating profit rose significantly by 194.4% to HK$368 million. Operating margin was up by 5.9 ppts to 9.6%.
• EBITDA increased sharply by 82.7% to HK$645 million with a corresponding EBITDA margin expanded by 6.5 ppts to 16.8%.

2

Compared to the nine months ended 30 September 2018 ("9M2018"), the unaudited financial information of the Group for 9M2019:

• Revenue increased by 9.1% (13.6% at constant exchange rate) to HK$11,729 million, of which HK$9,634 million was from the Tissue segment and HK$2,095 million was from the Personal Care segment.
• Gross profit grew by 10.2% to HK$3,420 million with a corresponding gross margin of 29.2%, increased by 0.3 ppt.
• Total foreign exchange loss was HK$48 million (9M2018: HK$65 million loss), of
  which HK$50 million loss was from operating payable items (9M2018: HK$58 million
  loss), and HK$2 million gain was from financing items (9M2018: HK$7 million loss).
• Operating profit rose by 29.8% to HK$998 million with a corresponding operating margin of 8.5%, expanded by 1.3 ppts.
• EBITDA increased by 24.1% to HK$1,824 million with a corresponding EBITDA margin improved by 1.9 ppts to 15.6%.

UNAUDITED THIRD QUARTER RESULTS FOR 2019Q3 AND 9M2019 OF ESSITY AKTIEBOLAG (PUBL)

Essity Aktiebolag (publ) ("Essity"), the Company's controlling shareholder, is a company listed on NASDAQ OMX Stockholm. As at the date of this announcement, Essity beneficially owns approximately 51.94% of the entire issued share capital of the Company.

Essity files financial reports which include quarterly financial information and certain operating statistics on a quarterly basis in accordance with the ongoing disclosure obligations applicable to a publicly traded listed company on NASDAQ OMX Stockholm. Such reports include segment financial information on the operations of the Company and are available in the public domain.

Essity will on or about 25 October 2019 release its unaudited financial results for the third quarter ended 30 September 2019. For details, please visit Essity's website: www.essity.com.

Shareholders and potential investors of the Company are advised that there is no indication or assurance from the Company that the unaudited financial information of the Group for 2019Q3 and 9M2019 will be the same as that presented in Essity's report for the third quarter of 2019.

3

Potential investors and shareholders of the Company are reminded that the above financial information has not been reviewed or audited by the Company's independent auditors. Subject to review and audit adjustment, differences may arise between such financial information and the data disclosed in the audited report. Potential investors and shareholders of the Company should exercise caution when dealing in the shares of the Company.

By order of the Board

Vinda International Holdings Limited

LI Chao Wang

Chairman

Hong Kong, 24 October 2019

As at the date of this announcement, the Board comprises:

Executive Directors:

Mr. LI Chao Wang

Ms. YU Yi Fang

Mr. Johann Christoph MICHALSKI

Mr. DONG Yi Ping

Ms. LI Jielin

Non-Executive Directors:

Mr. Jan Christer JOHANSSON

Mr. Carl Magnus GROTH

Mr. Carl Fredrik Stenson RYSTEDT

Independent Non-Executive Directors:

Mr. CHIA Yen On

Ms. LEE Hsiao-yun Ann

Mr. TSUI King Fai

Mr. WONG Kwai Huen, Albert

Alternate Director:

Mr. Gert Mikael SCHMIDT (alternate to Mr. JOHANSSON and Mr. GROTH)

4